Humanigen Inc (fka HGENQ)

[PITrader87]

"Humanigen initiated with an Outperform at Oppenheimer Oppenheimer analyst Kevin DeGeeter initiated coverage of Humanigen with an Outperform rating and $30 price target."

That $30 PT pairs nicely with the options action today..

Also interesting the expiration corresponds with this timeline stated in a reuters article today:

EU plans faster approval, new joint purchases of COVID-19 drugs

"The Commission also said it would draw up a portfolio of 10 potential COVID-19 therapeutics and will identify the five most promising ones by June"

https://www.reuters.com/article/us-health-coronavirus-eu-drugs-idUSKBN2CN195